Glenmark bags FDA approval for new generic
24 June 2016 | News | By BioSpectrum Bureau
Glenmark bags FDA approval for new generic
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram, the generic version of Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram of Taro.
Glenmark Pharmaceuticals Inc., USA (Glenmark) has also been granted tentative approval by the United States Food & Drug Administration (US FDA) for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar Tablets of Daiichi Sankyo, Inc
